Literature DB >> 11015305

Influence of beta-adrenoceptor tone on the cardioprotective efficacy of adenosine A(1) receptor activation in isolated working rat hearts.

W R Ford1, B I Jugdutt, G D Lopaschuk, R Schulz, A S Clanachan.   

Abstract

This study investigated the role of beta-adrenoceptors in the cardioprotective and metabolic actions of adenosine A(1) receptor stimulation. Isolated paced (300 beats min(-1)) working rat hearts were perfused with Krebs-Henseleit solution containing 1.2 mM palmitate. Left ventricular minute work (LV work), O(2) consumption and rates of glycolysis and glucose oxidation were measured during reperfusion (30 min) following global ischaemia (30 min) as well as during aerobic conditions. Relative to untreated hearts, N(6)-cyclohexyladenosine (CHA, 0.5 microM) improved post-ischaemic LV work (158%) and reduced glycolysis and proton production (53 and 42%, respectively). CHA+propranolol (1 microM) had similar beneficial effects, while propranolol alone did not affect post-ischaemic LV work or glucose metabolism. Isoprenaline (10 nM) impaired post-ischaemic function and after 25 min ischaemia recovery was comparable with 30 min ischaemia in untreated hearts (41 and 53%, respectively). Relative to isoprenaline alone, CHA+isoprenaline improved recovery of LV work (181%) and reduced glycolysis and proton production (64 and 60%, respectively). In aerobic hearts, CHA, propranolol or CHA+propranolol had no effect on LV work or glucose oxidation. Glycolysis was inhibited by CHA, propranolol and CHA+propranolol (50, 53 and 52%, respectively). Isoprenaline-induced increases in heart rate, glycolysis and proton production were attenuated by CHA (85, 57 and 53%, respectively). The cardioprotective efficacy of CHA was unaffected by antagonism or activation of beta-adrenoceptors. Thus, the mechanism of protection by adenosine A(1) receptor activation does not involve functional antagonism of beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015305      PMCID: PMC1572354          DOI: 10.1038/sj.bjp.0703597

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes.

Authors:  D Martens; M J Lohse; B Rauch; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

2.  Adenosine attenuation of catecholamine-enhanced contractility of rat heart in vivo.

Authors:  F D Romano; T S Naimi; J G Dobson
Journal:  Am J Physiol       Date:  1991-05

Review 3.  Protons in ischemia: where do they come from; where do they go to?

Authors:  S C Dennis; W Gevers; L H Opie
Journal:  J Mol Cell Cardiol       Date:  1991-09       Impact factor: 5.000

Review 4.  The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH.

Authors:  M Lazdunski; C Frelin; P Vigne
Journal:  J Mol Cell Cardiol       Date:  1985-11       Impact factor: 5.000

5.  The role of propranolol's negative chronotropic effect on protection of the ischemic myocardium.

Authors:  L D Hillis; S F Khuri; E Braunwald; P R Maroko
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

6.  Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.

Authors:  G Richardt; W Waas; R Kranzhöfer; E Mayer; A Schömig
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

7.  Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts.

Authors:  J G Dobson; R W Ordway; R A Fenton
Journal:  Am J Physiol       Date:  1986-08

8.  Endogenous adenosine improves work rate to oxygen consumption ratio in catecholamine stimulated isovolumic rat heart.

Authors:  J Headrick; R J Willis
Journal:  Pflugers Arch       Date:  1989-02       Impact factor: 3.657

9.  Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.

Authors:  J D Thornton; G S Liu; R A Olsson; J M Downey
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

10.  Attenuation by atenolol of myocardial acidosis during ischemia in dogs: contribution of beta-1 adrenoceptors to myocardial acidosis.

Authors:  K Sakai; Y Abiko
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.